Brief: Orexo To Resolve Patent Litigation With Sun In US

Orexo AB

16/12/2024 07:53

Dec 16 (Reuters) - Orexo AB  ORX.ST :
    * SAID ON SUNDAY ENTERED INTO SETTLEMENT AGREEMENT WITH SUN
TO
RESOLVE PATENT LITIGATION REGARDING ZUBSOLV SUBLINGUAL TABLET,
FOR TREATMENT OF OPIOID USE DISORDER IN US
    * AGREEMENT RESOLVES PATENT LITIGATION COMMENCED IN 2020 BY
OREXO
FOLLOWING SUN'S FILING OF ABBREVIATED NEW DRUG APPLICATION 
    * AGREEMENT ALLOWS SUN TO ENTER US MARKET WITH ITS GENERIC
VERSIONS OF ZUBSOLV IN SEPT 2030
    * ZUBSOLV IS PROTECTED BY TEN PATENTS IN US WITH EXPIRATION
DATES
RANGING FROM 2027 TO 2032

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nMFN3frnWB
 Further company coverage:  ORX.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))